论文部分内容阅读
目的探讨孟鲁斯特钠在儿童支原体肺炎恢复期咳嗽治疗中的作用。方法 82例学龄儿童,按随机排列表法分为治疗组和对照组,前者给予孟鲁斯特钠口服,后者给予丙卡特罗口服。比较2组最大呼气峰流速(PEF)及咳嗽症状消失时间。结果治疗组与对照组PEF〔(167±12)vs(170±8)L/min,P>0.05〕、咳嗽消失时间〔(5.4±1.3)vs(5.1±1.8)d,P>0.05〕比较,差异无统计学意义。结论孟鲁斯特钠可以作为缓解儿童肺炎支原体感染后咳嗽症状的药物之一。
Objective To investigate the role of monastuside in the treatment of childhood cough during mycoplasma pneumoniae convalescence. Methods 82 cases of school-age children were randomly divided into treatment group and control group. The former was given oral sodium montelukast and the latter oral procaterol. The maximum expiratory peak velocity (PEF) and disappearance of cough were compared between the two groups. Results Compared with the control group, PEF 〔(167 ± 12) vs (170 ± 8) L / min, P> 0.05〕, cough disappear time 〔(5.4 ± 1.3) vs (5.1 ± 1.8) d, P> 0.05〕 ,The difference was not statistically significant. Conclusion Montelukast sodium can be used as one of the drugs to relieve the cough symptoms of children with Mycoplasma pneumoniae infection.